Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: addendum: medications adjusted. discharge medications: 1. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day) for 1 months. disp:*60 capsule(s)* refills:*0* 2. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day) for 1 months. disp:*60 tablet(s)* refills:*0* 3. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*0* 4. lisinopril 10 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 5. fluticasone 50 mcg/actuation spray, suspension sig: one (1) spray nasal daily (daily). disp:*qs * refills:*0* 6. tramadol 50 mg tablet sig: one (1) tablet po q4h (every 4 hours) as needed. disp:*60 tablet(s)* refills:*0* 7. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*0* 8. amiodarone 200 mg tablet sig: two (2) tablet po bid (2 times a day): 400mg 2x/day x 1 week, then 200mg 2x/day x 1 week, then 200mg daily. disp:*120 tablet(s)* refills:*0* 9. imitrex 50 mg tablet sig: one (1) tablet po once a day as needed for headache: may repeat x1 if symptoms not resolved after 2 hours. disp:*20 tablet(s)* refills:*0* 10. furosemide 20 mg tablet sig: one (1) tablet po once a day for 1 weeks. disp:*7 tablet(s)* refills:*0* 11. potassium chloride 20 meq tab sust.rel. particle/crystal sig: one (1) tab sust.rel. particle/crystal po once a day for 1 weeks. disp:*7 tab sust.rel. particle/crystal(s)* refills:*0* discharge disposition: home with service facility: vna md procedure: extracorporeal circulation auxiliary to open heart surgery intraoperative cardiac pacemaker diagnostic ultrasound of heart open heart valvuloplasty of mitral valve without replacement diagnoses: mitral valve disorders asthma, unspecified type, unspecified other postprocedural status examination of participant in clinical trial migraine, unspecified, without mention of intractable migraine without mention of status migrainosus 

Answer: The patient is high likely exposed to